This Community is Archived.

This community is no longer active as of December 2018. Thanks to those who posted here and made this information available to others visiting the site.

Moderators

Bio

Rivet is a research scientist at the University of Connecticut’s Center for Health, Innovation, and Prevention, and also works with Applied Health Research as a developer and trainer of interventions that use communication and counseling theory to support adherence and retention in the context of clinical trials and resource limited settings. Methodology, design, measurement, and analytic strategies in cross-sectional and longitudinal designs are also of interest. The development of interventions to support medication and treatment adherence that are ecologically valid, culturally competent, and highly translatable to practical settings guides much of my research and project development to date. As a co-developer of the IMB-model of HAART adherence and the developer of the situated-Information Motivation Behavioral Skills model of care initiation and maintenance (sIMB-CIM), Rivey firmly believes in the potential contributions that theorists and methodologists can make in efforts to promote health behavior. The intersection between medicine, behavioral science, and systems of care offers the unique opportunity for health psychologists to actively contribute to multidisciplinary teams and shape the direction of behavioral interventions for promotion of health and clinical outcomes for those struggling with chronic medical conditions. This is particularly the case in HIV care, as this cohort is aging and the proportion of those dealing with co-morbities continues to increase. Similarly, in areas where diet and lifestyle are the targets of recommended treatment, sophisticated strategies for supporting engagement in care must address broad compendiums of treatment recommendations and not just adherence to medication. It is in these areas that my program of research seeks to develop and evaluate comprehensive models and model-based interventions.

Work Location

  • United States

Organization

  • University of Connecticut

Bio

David Bangsberg is the director of International Programs at the Ragon Institute of MGH, MIT and Harvard, Associate Professor of Medicine at Harvard School of Medicine, and the director of the International Program for the Harvard University Center for AIDS Research. Dr. Bangsberg received his medical degree from Johns Hopkins University and holds a Master of Science from Kings College at the University of London and a Master of Public Health from the University of California, Berkeley. Dr. Bangsberg has researched and published extensively on adherence to antiretroviral medications in treating HIV/AIDS and has collaborations across sub-Saharan Africa. Research: Focused on HIV in impoverished populations. In 1996, Dr. Bangsberg launched a series of studies in HIV+ homeless and marginally housed individuals in response to concerns that poor adherence to HIV antiretroviral treatment in the urban poor would create new strains of drug resistant virus. He described the challenges in providing antiretroviral therapy to the urban poor, developed valid measures of adherence, defined the risk of antiretroviral resistance by level of adherence, and developed effective interventions to improve adherence in the HIV+ urban poor. These studies mitigated what we now recognize were exaggerated concerns regarding HIV drug resistance in the urban poor and helped shift the debate from withholding treatment to maximizing treatment effectiveness.

Work Location

  • United States

Organizations

  • Harvard Global Health Institute
  • Harvard Medical School
  • Massachusetts General Hospital - MGH

Bio

Peter Ehrenkranz is currently Medical Officer & Care and Treatment Team Lead/Advisor for CDC/PEPFAR-Swaziland. Formerly he was the Medical Director of the Clinton HIV/AIDS Initiative’s programs in Liberia. His primary role was to serve as Senior Technical Advisor to the National AIDS and STI Control Program. He also advised the National Leprosy and Tuberculosis Control Program (NLTCP) and the National Blood Safety Program. His work focuses on improving access to quality prevention, care and treatment for HIV and TB, but, as much as possible, he strives to leverage the resources available to the vertical programs to strengthen the entire health system. He received his undergraduate degree in the History of Science and Medicine from Yale University, and medical and public health degrees from Emory University. He trained in internal medicine-primary care at the University of Pennsylvania where he also participated in the Robert Wood Johnson Clinical Scholars Program. He is an Adjunct Assistant Professor of Medicine in the Division of General Medicine at the University of Pennsylvania and a Lecturer in the Department of Health Policy, Division of Epidemiology and Public Health at Yale University.

Work Location

  • Swaziland

Organization

  • PEPFAR - The U.S. President's Emergency Plan for AIDS Relief

Bio

Jessica Haberer, MD, received a bachelor's degree in the Biological Sciences and a master's degree in Health Services Research from Stanford University, as well as a medical degree from Yale University. She completed an internship and residency in Internal Medicine at the University of California, San Francisco. After finishing her training, Dr. Haberer worked for the William J. Clinton Foundation HIV/AIDS Initiative in Beijing, China, where served as a Clinical and Research Advisor to the Chinese Center for Disease Control and Prevention/ National Center for AIDS, Division of Treatment and Care. Upon returning to the United States, she joined the faculty in the Department of Medicine at the University of California, San Francisco as a Clinical Educator. Dr. Haberer developed in interest in adherence to HIV antiretroviral therapy (ART) while in China and began studying multiple measures of ART adherence among children and adults in developing settings. Dr. Haberer joined Massachusetts General Hospital and the Harvard Initiative for Global Health in 2008, where she is actively involved in the study of wireless adherence monitoring technologies and strategies for developing settings, as well as adherence to pre-exposure prophylaxis against HIV infection.

Work Location

  • United States

Organizations

  • Harvard Global Health Institute
  • Massachusetts General Hospital - MGH

Bio

Dr. Haidar is a Research Fellow at the Global Health Delivery (GHD) project and Harvard Medical School’s Department of Global Health and Social Medicine (DGHSM). Before coming to Boston she worked in Lesotho as Director of the Bobete clinic for the HIV Rural Initiative of Partners In Health Lesotho. She is currently working alongside GHD and DGHSM faculty on research and academic products designed to train global health delivery instructors and implementers. Meanwhile, she is developing a social medicine curriculum to be implemented at Lebanese American University in Lebanon, where she will return to assume a faculty position upon the conclusion of her fellowship. Dr. Haidar received her MD from the American University of Beirut in Lebanon in 2003; she also completed her clinical training in Internal Medicine there from 2003 to 2006. She expects to receive her Masters in Public Health from Harvard School of Public Health in 2009. Read an interview on the GHD Website about my work in Lesotho: http://globalhealthdelivery.org/blog/?p=274

Work Location

  • Lebanon

Organizations

  • Global Health Delivery Project
  • Harvard Medical School, Department of Global Health and Social Medicine
  • Lebanese American University
  • Partners In Health - PIH

Bio

Joia Mukherjee, MD, MPH is an expert in the scale up of treatment for complex disease in poor countries. As Medical Director of Partners In Health, she has overseen the expansion of successful HIV/AIDS treatment programs to eight hospitals in Haiti and six clinics in rural Rwanda, as well as the scale up of treatment programs for multi-drug resistant tuberculosis nationwide in Peru and to 14 states in the Russian Federation. In 2006, Dr. Mukherjee served as Editor-in-Chief for the 2nd edition of Partners In Health’s Community-Based Treatment of HIV in Resource Poor Settings, the leading publication of its kind for health care professionals worldwide. She is also a respected voice in global health policy, and in 2006 was a leading contributor to new World Health Organization standards for treating HIV positive children in poor settings and for management of multi-drug resistant tuberculosis. She is a sought after teacher and speaker at a wide range of venues around the world, having lectured at universities and major medical conferences in 14 countries. She is also an extensively published and well-respected researcher, who is currently principal investigator on three studies examining various aspects of her work in Haiti. Dr. Mukherjee received her MD from the University of Minnesota in Minneapolis in 1992, followed by clinical training in Internal Medicine and Pediatrics at the University of Minnesota Hospital and Clinic from 1992 to 1994 and at Massachusetts General Hospital from 1995 to 1997. She was a Fellow in Infectious Disease at Massachusetts General Hospital and Brigham and Women’s Hospital from 1997 to 2001. In 1998, she received the Fellow in Training Award from the Infectious Disease Society of America. She received her Masters in Public Health from the Harvard School of Public Health in 2001. She is board certified in Internal Medicine, Pediatrics, and Infectious Disease.

Work Location

  • United States

Organizations

  • Brigham and Women's Hospital, Division of Global Health Equity
  • Harvard Medical School, Department of Global Health and Social Medicine
  • Partners In Health - PIH

Bio

Jean B. Nachega, MD, PhD, MPH, DTM&H: Associate Professor of Medicine and Epidemiology, Department of Epidemiology, Infectious Epidemiology Program at Graduate School of Public Health, Pittsburgh University. Adjunct Associate Professor, Departments of Epidemiology and International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA. Part-time Director, Center for Infectious Diseases, Stellenbosch University, Cape Town, South Africa; Professor Extraordinary, Department of Medicine, Stellenbosh University, Cape Town, South Africa. Visiting Professor of Medicine, University of Liege, Liege, Belgium. Dr Nachega is an infectious Diseases-Internist trained Epidemiology, Health Economics, and Tropical Medicine and Public Health in Belgium (University of Louvain), United Kingdom (London School of Hygiene and Tropical Medicine), USA (Johns Hopkins University & Harvard University). His research, teaching, and professional activities include planning, design, implementing, and monitoring clinical trials, cohort studies and programs for prevention and treatment of HIV/AIDS and related opportunistic infections globally. Dr Nachega serves as the Principal Investigator on several research or training grants funded by NIH, PEPFAR, EDCTP, Wellcome Trust and Private Foundations. He is an ad hoc expert member at World Health Organization, HIV Department, Geneva, within the HIV Treatment Guidelines as well as HIV Drug Resistance Working Groups. He is member of South African Academy of Sciences. Faculty Websites: http://www.epidemiology.pitt.edu/nachega.asp http://www.jhsph.edu/faculty/directory/profile/1040/Nachega/Jean_B.

Work Location

  • South Africa

Organization

  • University of Pittsburgh School of Medicine